
Supreme Court Decision on Genetic Patents Shifts Biotech IP Landscape
The U.S. Supreme Court recently issued a mixed decision on the patentability of human genes. The justices concluded that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but that cDNA (complimentary DNA) is patent eligible because it is not naturally occurring. The patents […]
Author: Kenneth C. Oh